Assoc. Prof. Constantine Tam | ICML 2017 | Ibrutinib + venetoclax in R/R MCL

Ibrutinib + venetoclax in R/R MCL

Lymphoma Hub Satellite Symposium 2019 | Chemo-free approaches in MCL - Professor Simon Rule

Professor Simon Rule discussed the novel chemotherapy-free treatment approaches in MCL during the Lymphoma Hub Satellite Symposium at 15-ICML.

Lymphoma Hub Satellite Symposium 2019 | Chemo-free approaches in MCL - Professor Simon Rule

Professor Simon Rule discussed the novel chemotherapy-free treatment approaches in MCL during the Lymphoma...

Results from the OAsis phase I/II trial on ibrutinib, venetoclax plus obinutuzumab in patients with newly diagnosed mantle cell lymphoma

During the 2020 European Hematology Association (EHA) Annual Congress, Steven Le Gouill presented data from...

Results from the OAsis phase I/II trial on ibrutinib, venetoclax plus obinutuzumab in patients with newly diagnosed mantle cell lymphoma

During the 2020 European Hematology Association (EHA) Annual...

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox